Dog bliver 25- O- desacetylrifabutin AUC (0- 48) og Cmax henholdsvis 11 og 6 gange højere, hvilket potentielt kan føre til stigning i rifabutin relaterede bivirkninger, især uveitis.
However, 25-O-desacetylrifabutin AUC (0-48) and Cmax were increased 11-fold and 6- fold respectively, which could potentially lead to an increase of rifabutin related adverse events, notably uveitis.